Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-063524
Filing Date
2012-12-10
Accepted
2012-12-10 19:05:47
Documents
1
Period of Report
2012-12-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd362992.html 4  
1 FORM 4 rrd362992.xml 4 27342
  Complete submission text file 0001181431-12-063524.txt   28917
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Issuer) CIK: 0001113148 (see all company filings)

EIN.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INFINITY PHARMACEUTICALS, INC. 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Perkins Adelene Q (Reporting) CIK: 0001375124 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-31141 | Film No.: 121254612